Zhaoke Ophthalmology Receives Orphan Drug Designation from the U.S FDA for Melphalan Targeting Pediatric Retinoblastoma

Zhaoke Ophthalmology Enhances Global Presence Through Partnership with Top-Tier French Pharmaceutical Company FAREVA

Zhaoke Ophthalmology Announces NMPA Acceptance of New Drug Application for NVK002 (Atropine Sulphate Eye Drops 0.02%) for the Treatment of Myopia Progression in Children

Zhaoke Ophthalmology and Jamjoom Pharma Forge Landmark Partnership to Revolutionize Dry Eye Treatment in the Middle East

Zhaoke Ophthalmology Expands its Footprint in the U.S. Partnering with Leading US Pharma, Somerset Therapeutics LLC